Albeit with a non-bone-specific tracer, Acar et al. [73] using RFs aimed to distinguish lesions imaged via posttreatment [68Ga]Ga-PSMA-11 PET/CT as nonresponding and completely responding (sclerotic lesions) in 75 PCa patients with known bone metastasis. This evidence concerns the gene FOLH1 and posterior cortical atrophy.